Call Us:
Categories
Archives
- June 2024
- May 2024
- July 2023
- May 2022
- March 2022
- February 2022
- November 2021
- March 2021
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- July 2017
- March 2017
FDA requires boxed warning for asthma and allergy drug due to neuropsychiatric events
FDA requires boxed warning for asthma and allergy drug due to neuropsychiatric events
(CNN)The United States Food and Drug Administration revealed Wednesday it is needing a boxed caution– the firm’s most popular caution– for the asthma and allergic reaction medication montelukast, offered under the brand Singulair.
“The occurrence of neuropsychiatric occasions related to montelukast is unidentified, however some reports are severe, and lots of clients and healthcare specialists are not totally familiar with these threats,” stated Dr. Sally Seymour, director of the Division of Pulmonary, Allergy and Rheumatology Products in the FDA’s Center for Drug Evaluation and Research.
“Importantly, there are numerous other safe and efficient medications to deal with allergic reactions with comprehensive history of usage and security,” she stated.
The FDA reached this choice after re-evaluation of the dangers and advantages of montelukast compared to other readily available treatments that have actually gotten in the marketplace given that the drug was very first authorized in 1998. It figured out the threats of montelukast might surpass its advantages, particularly for individuals with moderate allergic reactions. If clients have actually stopped working or can not endure other treatments, it advises utilizing montelukast just.
In addition to the boxed caution, the FDA is likewise needing a brand-new Medication Guide to be provided to clients with montelukast prescriptions.
Read more: https://www.cnn.com/2020/03/05/health/fda-warning-for-asthma-and-allergy-drug/index.html
